Clinically meaningful endpoints included: 71% of patients achieved a greater than 30% reduction in the urine protein to cr Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical ...

The company develops site-specific and novel-format antibody drug conjugates (ADCs) that enables its proprietary integrated cell-free protein synthesis platform, XpressCF and XpressCF+.

Protein design (or protein engineering) is a technique by which proteins with enhanced or novel functional properties are created. Proteins can be engineered by rational design, which typically ...

Protein folding is the process by which proteins achieve their mature functional (native) tertiary structure, and often begins co-translationally. Protein folding requires chaperones and often ...